文献速递消化道肿瘤与早癌消化内镜

恶性胃出口梗阻患者内镜与外科胃空肠吻合术比较:2016-2020年全国队列分析

Comparison of endoscopic and surgical gastrojejunostomy in patients with malignant gastric outlet obstruction: a national cohort analysis (2016-2020).
PubMed 文献 · Gastrointest Endosc · 2025-01-25

基于美国全国住院患者样本(2016-2020年)的回顾性队列分析,纳入20,930例因恶性胃出口梗阻行胃空肠吻合术的成人患者,其中外科组16,585例、内镜组4,345例。内镜组呼吸衰竭、输血和腹膜炎的调整后比值比均较低,住院费用更低、住院时间更短,死亡率无显著差异。作者认为应强烈考虑内镜胃空肠吻合术。

要点

  • 内镜组呼吸衰竭4.7% vs 外科组7.4%(aOR 0.68,95%CI 0.48-0.96,P=.032)
  • 内镜组输血9.25% vs 外科组13.74%(aOR 0.63,95%CI 0.48-0.82,P=.001)
  • 内镜组住院时间平均9.88天 vs 外科组12.56天(调整后差值2.24天,95%CI 1.53-2.96,P<.001)

核心结论

  • 与外科胃空肠吻合术相比,内镜胃空肠吻合术与较低的围手术期不良事件发生率、住院费用和住院时间相关。
  • 作者认为,基于上述原因,在管理恶性胃出口梗阻时应强烈考虑内镜胃空肠吻合术。

研究设计与样本

  • 查询2016年至2020年全国住院患者样本(National Inpatient Sample),使用ICD-10编码识别因胃、胰腺或十二指肠癌主要诊断而接受内镜或外科胃空肠吻合术的成人住院患者。
  • 共纳入20,930例接受胃空肠吻合术的恶性胃出口梗阻患者,其中外科胃空肠吻合术16,585例,内镜胃空肠吻合术4,345例。

主要发现

  • 外科组胰腺癌比例36.16% vs 内镜组19.56%,外科组胃癌比例55.16% vs 内镜组71.99%。
  • 内镜组在东北部实施的比例20.33% vs 外科组27.66%(P<.001),在南部实施的比例30.56% vs 外科组39.52%(P<.001)。
  • 两组死亡率差异无统计学显著(0.62;95%CI 0.35-1.10;P=.106)。
  • 内镜组呼吸衰竭4.7% vs 外科组7.4%(aOR 0.68;95%CI 0.48-0.96;P=.032),输血9.25% vs 13.74%(aOR 0.63;95%CI 0.48-0.82;P=.001),腹膜炎2.19% vs 4.5%(aOR 0.55;95%CI 0.33-0.91;P=.022)。
  • 内镜组住院费用均值164,794美元 vs 外科组183,519美元(回归调整后差值16,495美元;95%CI 29,204-3,786;P=.011),住院时间均值9.88天 vs 12.56天(调整后差值2.24天;95%CI 1.53-2.96;P<.001)。

关键数值与推荐

  • 内镜组呼吸衰竭aOR 0.68(95%CI 0.48-0.96,P=.032),输血aOR 0.63(95%CI 0.48-0.82,P=.001),腹膜炎aOR 0.55(95%CI 0.33-0.91,P=.022)。
  • 内镜组住院费用调整后差值16,495美元(95%CI 29,204-3,786;P=.011),住院时间调整后差值2.24天(95%CI 1.53-2.96;P<.001)。

临床怎么用

  • 作者认为,基于内镜胃空肠吻合术与较低的围手术期不良事件、住院费用和住院时间相关,在管理恶性胃出口梗阻时应强烈考虑内镜胃空肠吻合术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Malignant gastric outlet obstruction (MGOO) is an unfortunate adverse event of advanced upper GI malignancies. Historically, surgical gastrojejunostomy (SGJ) has been the procedure of choice to achieve enteral bypass. Recently, endoscopic techniques have gained popularity in the management of MGOO. We aimed to compare periprocedural outcomes between SGJ and endoscopic gastrojejunostomy (EGJ) in patients with MGOO. METHODS: The National Inpatient Sample was queried from 2016 through 2020. The International Classification of Diseases, Tenth Revision, codes were used to identify adult admissions with a principal diagnosis of gastric, pancreatic, or duodenal cancer undergoing EGJ or SGJ. The 2 cohorts were compared for periprocedural adverse events. RESULTS: Of 20,930 patients undergoing gastrojejunostomy for MGOO, 16,585 underwent SGJ and 4345 underwent EGJ. The SGJ cohort had a higher proportion of patients with pancreatic cancer (36.16% vs 19.56%) and a lower proportion of patients with gastric cancer (55.16% vs 71.99%). A higher percentage of EGJs were performed in the Northeast (20.33% vs 27.66%, P < .001), whereas a smaller percentage of EGJs were performed in the South (30.56% vs 39.52%, P < .001). Between the 2 groups, the difference in mortality rates was not significantly different (0.62; 95% CI, 0.35-1.10; P = .106), but the EGJ group had lower odds of respiratory failure (4.7% vs 7.4%; adjusted odds ratio [aOR], 0.68; 95% CI, 0.48-0.96; P = .032), blood transfusion (9.25% vs 13.74%; aOR, 0.63; 95% CI, 0.48-0.82; P = .001), and peritonitis (2.19% vs 4.5%; aOR, 0.55; 95% CI, 0.33-0.91; P = .022). The EGJ group had lesser hospitalization charges (mean $164,794 vs $183,519; adjusted difference on regression, $16,495; 95% CI, 29,204-3786; P = .011) and shorter hospital stays (mean, 9.88 vs 12.56 days; adjusted difference, 2.24 days; 95% CI, 1.53-2.96; P < .001). The use of EGJ increased over 5 years (16.86% in 2016 to 24.14% in 2020, P for trend = .002), whereas the use of SGJ decreased (83.13% in 2016 to 75.85% in 2020, P for trend = .002). CONCLUSIONS: Compared with SGJ, EGJ is associated with lower rates of periprocedural adverse events, hospitalization charges, and length of stay. For these reasons, EGJ should be strongly considered in managing MGOO.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Pinnam BSM, Ojemolon PE, Mohammed A, et al. Comparison of endoscopic and surgical gastrojejunostomy in patients with malignant gastric outlet obstruction: a national cohort analysis (2016-2020). Gastrointest Endosc. 2025. PMID: 39870244. doi:10.1016/j.gie.2025.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。